Trial Profile
In-Practice Evaluation of Atacand 16mg Antihypertensive Effect.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 04 Dec 2010
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 02 Dec 2010 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 02 Dec 2010 Actual initiation date (Nov 2008) added as reported by ClinicalTrials.gov.
- 20 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.